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Abstract
Background: Kaposi's Sarcoma (KS) is a proliferation of aberrant vascular structures lined by
spindle cells, and is caused by a gammaherpes virus (HHV8/KSHV). Its course is aggravated by co-
infection with HIV-1, where the timing of infection with HIV-1 and HHV8 is important for the
clinical outcome.
Methods: In order to better understand the pathogenesis of KS, we have analysed tissue from two
AIDS-KS lesions, and from normal skin by serial analysis of gene expression (SAGE). Semi-
quantitative RT-PCR was then used to validate the results.
Results: The expression profile of AIDS-related KS (AIDS-KS) reflects an active process in the
skin. Transcripts of HHV8 were found to be very low, and HIV-1 mRNA was not detected by
SAGE, although it could be found using RT-PCR. Comparing the expression profile of AIDS-KS
tissue with publicly available SAGE libraries suggested that AIDS-KS mRNA levels are most similar
to those in an artificially mixed library of endothelial cells and leukocytes, in line with the
description of KS lesions as containing spindle cells with endothelial characteristics, and an
inflammatory infiltrate. At least 64 transcripts were found to be significantly elevated, and 28 were
statistically downregulated in AIDS-KS compared to normal skin. Five of the upregulated mRNAs,
including Tie 1 and sialoadhesin/CD169, were confirmed by semi-quantitative PCR to be elevated
in additional AIDS-KS biopsies. Antibodies to sialoadhesin/CD169, a known marker of activated
macrophages, were shown to specifically label tumour macrophages.
Conclusion: The expression profile of AIDS-KS showed 64 genes to be significantly upregulated,
and 28 genes downregulated, compared with normal skin. One of the genes with increased
expression was sialoadhesin (CD169). Antibodies to sialoadhesin/CD169 specifically labelled
tumour-associated macrophages, suggesting that macrophages present in AIDS-KS lesions belong
to a subset of human CD169+ macrophages.
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Background
Kaposi's sarcoma (KS) was first described more than 120
years ago. This "classical" variant is rare and usually limit-
ed to elderly men, although an aggressive form was subse-
quently found to occur in young people in Africa
designated "African endemic variant". KS is also observed
in organ transplant recipient patients who have previously
received immunosuppressive therapy designated "post
transplant KS" [1]. The fourth form "epidemic or AIDS-re-
lated" is KS associated with HIV-1 infection (AIDS-KS)
[2]. This variant is predominantly found in homosexual
or bisexual men where it develops in 15–30% of patients
during the course of infection. AIDS-KS is the most com-
mon tumour seen in patients with HIV-1 infection and
can become widely disseminated with the involvement of
visceral organs.
A viral aetiology for KS has been suspected since the early
1970s. In 1994, Chang et al. [3] identified two fragments
of herpesvirus-like DNA in the lesions of a patient with
AIDS-KS. Since this discovery of Kaposi's Sarcoma-associ-
ated Herpes Virus (KSHV), also named Human Herpes Vi-
rus 8 (HHV8), there is a strong epidemiological case for a
causative role of this virus in the pathogenesis of all KS
types [4].
KS lesions have a complex histology, are localized to the
dermis, and are characterized by a proliferation of aber-
rant vascular structures lined by spindle cells. Despite
their morphological homogeneity, these KS spindle cells
represent a heterogeneous population dominated by acti-
vated endothelial cells mixed with fibroblasts, macro-
phages and dendritic cells [5]. Several histological features
of KS lesions suggest that they represent polyclonal prolif-
erations rather than true tumours, at least at the early stag-
es. Genomic sequencing has revealed that HHV8 contains
several genes with likely oncogenesis related functions
that subvert pathways involved in cellular activation, pro-
liferation, differentiation, and survival (see e.g. [6]).
In contrast to the first three KS variants, a second virus,
HIV-1, is involved in AIDS-KS. Although the mechanism
is still unknown, HIV-1 infection greatly enhances the oc-
currence of KS in HHV8 infected patients. Earlier research
indicated that the timing of infection with HIV-1 and
HHV8 is essential for the clinical outcome. Patients sero-
converting for HHV8 after HIV infection are at a higher
risk to develop AIDS-KS than those who seroconvert for
HHV8 before HIV infection [4,7]. Genes differentially ex-
pressed in AIDS-KS could provide insight into disease pro-
gression, and provide molecular markers to monitor
patients at risk. These genes should preferably also be dif-
ferentially expressed between patient PBMCs and those of
healthy controls for easier monitoring. Assuming the ex-
istence of such genes is not inappropriate, as both viruses
are present in PBMCs [8], and cells with KS spindle cell
properties can be grown from AIDS-KS patient blood
[9,10].
In an effort to identify such potential molecular markers
for the development of AIDS-KS in HHV8/HIV-1 double-
infected patients, we have analysed gene expression pro-
files of two AIDS-KS skin lesions with the serial analysis of
gene expression (SAGE) technique. SAGE is a powerful
technique that allows large-scale analysis of gene expres-
sion in a tissue of interest [11], including eventual viral
transcripts. Comparison of the global gene expression pat-
terns generated by SAGE to a control tissue would allow
the identification of differentially expressed genes.
Methods
Patient material
Kaposi's sarcoma skin tissue was obtained from two ho-
mosexual male AIDS patients, living in The Netherlands.
Patient 1 was demonstrated to be HIV-1 positive in 1982.
In 1985 a histological examination confirmed the diagno-
sis of Kaposi's sarcoma. He died 13 month later and post
mortem examination revealed morphological variants of
visceral AIDS-KS. Patient 2 presented in 1984 at the AMC
with progressive AIDS-KS skin lesions. Subsequently, in-
ternal organs were affected, and the patient died in 1986.
Normal adult breast skin tissue was obtained as discarded
tissue from reduction mammoplasties (obtained from the
Department of Plastic Surgery of our hospital). RNA iso-
lated of three breast reductions, mixed in equal amounts,
was used to construct the normal skin expression profile
library.
Immunohistochemistry
Frozen sections were cut with a microtome, fixed with ac-
etone and stained with mABs to CD3, CD31, CD68, or
CD169/sialoadhesin. CD3, CD31, and CD68 antibodies
were obtained from Dako (Glostrup, Denmark), anti-
CD169 antibodies were from Serotec (Oxford, UK).
Serial Analysis of Gene Expression (SAGE)
SAGE libraries were constructed from frozen skin biopsies
taken at autopsy from both AIDS-KS patients. The two bi-
opsies were cut with a microtome in 10–14 µm sections
for RNA isolation, while 5 µm slides were prepared for
histological examination. Total RNA was isolated with the
Trizol method (Life Technologies, San Diego CA, USA).
Poly A+ mRNA was further isolated using the Micro-Fast-
Track 2.0 mRNA purification kit (Invitrogen, Carlsbad CA,
USA). SAGE was performed as described previously [12].
In brief, poly A+ RNA was converted to double-stranded
cDNA with Superscript II RNAse H- Reverse Transcriptase
(Life Technologies, San Diego CA, USA) and a primer bi-
otin-5'-T18-3'. The cDNA was then cleaved with NlaIII,BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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and the 3'restriction fragments were bound to streptavi-
din-coated magnetic beads (Dynabeads M280 from Dy-
nal, Oslo, Norway). After ligation of oligonucleotides
containing recognition sites for BsmF1, the linkered cDNA
was released from the beads by digestion with BsmF1. The
released tags were ligated to each other to create ditags,
and amplified by polymerase chain reaction (PCR). Am-
plified ditags were subsequently concatenated and cloned
into the Sph1 site of pZero 1.0 (Invitrogen, Carlsbad CA,
USA). Colonies were screened by PCR, using M13 forward
and M13 reverse primers, and inserts were sequenced with
the Bigdye Terminator Cycle Sequencing kit (ABI, Foster
City CA, USA) and analysed using an ABI 377 automated
sequencer (ABI, Foster City CA, USA).
Three SAGE libraries were constructed: KSa derived from
AIDS-KS skin tissue of patient 1, KSb derived from AIDS-
KS skin tissue of patient 2, and NS, a normal skin library
derived from RNA isolated from three samples of normal
skin. SAGE libraries have been submitted to Gene Expres-
sion Omnibus (GEO) at http://www.ncbi.nlm.nih.gov/
geo/, with the following accession numbers: GSM3240
(KSa), GSM3241 (KSb) and GSM3242 (NS).
Analysis of SAGE libraries
Primary analysis of the SAGE libraries was performed with
USAGE version2 [13]. This program does initial analyses
on raw sequence data, e.g. ditag and tag extraction, tag
counting, and tag identification. Tags were identified with
the SAGEmap database available through NCBI, to which
USAGE is directly linked. Viral tags were identified with a
SAGE tag database created for this project by extracting all
relevant SAGE tags from the viral cDNA sequences present
in the NCBI database http://www.ncbi.nlm.nih.gov/ent-
rez. This viral tag database has been implemented in US-
AGE. The program USAGE was also used to compare
taglists, and to do statistical analyses on tag count
differences.
Besides USAGE, the SAGE libraries were analysed with the
Human Transcriptome Map (HTM) [14]. In this program,
tags have been mapped to 18,422 human genes and their
respective chromosome locations. HTM identifies all pos-
sible tags of a single transcript at a certain chromosome
position. For highly expressed genes, very often more than
one tag is found in SAGE libraries, due to alternative splic-
ing, and/or alternative polyadenylation. Additionally, the
pooled KS library was compared with several public
databases.
Confirmation RT-PCR
Six SAGE tags were identified as more frequently ex-
pressed in AIDS-KS than in normal skin, and in all public
SAGE libraries at the time of analysis (NCBI CGAP). The
RNA preparations used to construct the SAGE libraries
were further used for tag confirmation [15]. RNA samples
were treated with DNaseI (Roche Diagnostics, Almere,
The Netherlands). First strand cDNA synthesis was
primed with an oligo(dT)18 with a 5' M13 tail (5' ctgagtt-
gtaaaacgcggccag-(t)18 -3') and transcribed with AMV-RT
[16]. For the PCR we used a tag specific primer consisting
of 10 nt identified in the SAGE analysis with a 5'NlaIII re-
striction site (catg) and 5' inosine nucleotides to increase
the annealing temperature of the primers and a 20 nt
primer corresponding to the 5'tail of the oligo (dT) primer
(5'ctgagttgtaaaacgcggccag-3'). PCR was performed using
standard conditions [16]. PCR fragments were cloned in a
TA cloning system (Invitrogen, San Diego, CA,) and sever-
al clones were sequenced.
RT-PCR amplification of selected targets
A limited-dilution RT-PCR was developed for each of the
six selected genes. The RT-PCR assays were nested PCR re-
actions, optimised to amplify 1–5 cDNA copies. Primers
were obtained from Invitrogen Life Technologies (San Di-
ego, CA). Primer sequences are shown in Table 1. To con-
firm specificity of the primer sets, the RT-PCR products
were cloned and sequenced before testing of any patient
material. Total RNA, isolated from five newly selected dif-
ferent AIDS-KS lesions, staining positive for HHV8 and
CD31, and two normal skin tissue samples (both negative
for HHV8 and CD31 staining), was DNase treated before
use. DNA contamination was tested by a minus RT-PCR.
All selected genes were normalized to the input RNA (500
ng), which concentration was measured by OD. The input
RNA was diluted in 10-fold steps. HHV8 DNA and HIV-1
RNA were amplified as controls from patient material us-
ing nested PCRs [17]. For the detection of HIV-1 RNA a
nested RT-PCR was used [16]. Normal skin samples were
negative for both viruses (results not shown).
Results
Histological staining of AIDS-KS tissue used in the analysis
All tissues were collected, snap frozen, and stored at -
80°C. Histological staining was performed on the frozen
tissue. Both AIDS-KS skin biopsies showed a similar his-
topathological picture of nodular advanced-stage Kaposi's
sarcoma with irregular, dense areas of spindle cell prolif-
erations (Fig. 1, panel D/G). Ziehl-Neelsen, grotcott and
PAS staining showed the KS tissues to be negative for my-
cobacteria and fungi (data not shown). The control skin
tissue had a normal morphology (Fig. 1, panel A).
Immunohistochemistry demonstrated that in both AIDS-
KS lesions the atypical spindle cells were CD31+. About
70–80% of the cells in the AIDS-KS tissue was stained
with anti-CD31, while only 2–5% was stained in the nor-
mal skin (Fig. 1, panel B/E/H). The αCD3 staining showed
that in both AIDS-KS tissues the percentage inflammatory
cells is low, with a slightly increased staining in KSb, andBMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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almost no staining in normal skin (Fig. 1, panel C/F/I).
So, overall histological examination suggests that both
AIDS-KS tissues are very similar.
Description of the SAGE libraries
A total of 130,521 tags were analysed, approximately one
third from KSa (45,913 tags), KSb (47,316 tags) and
37,292 tags from NS. Only 2,6%-3,0% of the tags oc-
curred five times or more, 3518, 3444 and 2908 were seen
between two and four times, and 11,326, 12,075 and
11373 tags occurred only once (Table 2), respectively. The
frequency distribution fits with the overall pattern of gene
expression in mammalian cells, wherein only a few per-
cent of mRNA species reaches high copy numbers whereas
most transcripts display low levels [18].
Similarities between the global expression profiles of dif-
ferent samples can be readily visualized using scatter
plots, and quantified through the calculation of a Pearson
correlation coefficient. As expected, both AIDS-KS sam-
ples are much more similar to each other than each of
them is to normal skin (average correlation coefficient of
0.83 versus 0.68 and 0.63, respectively; figure 2).
So, based on histological staining, tag frequency distribu-
tion and comparison of gene expression profiles, we con-
cluded that both AIDS-KS tissues are very similar and have
similar mRNA expression profiles.
Viral transcripts in the AIDS-KS SAGE libraries
The presence of HHV8 DNA in the two AIDS-KS lesions
was tested with a nested HHV8 PCR [17]. Both AIDS-KS
lesions were HHV8 DNA positive (data not shown) and
also expressed HHV8 RNA. HHV8 specific tags found in
the two SAGE libraries are presented in Table 3. The find-
ing of tags corresponding to T1.1 and T0.7 transcripts
agrees well with the observation that these two transcripts
represent the bulk of the virus-specific RNA extracted from
AIDS-KS tumours [19]. HIV-1 RT PCR confirmed the pres-
ence of HIV-1 RNA in both lesions (data not shown).
Comparison of AIDS-KS with public SAGE libraries
Early KS is a reactive process of polyclonal nature, where
lesion development is induced by immune dysregulation
and production of inflammatory cytokines. In later stages,
KS can then progress into a true sarcoma. KS lesions are
composed of endothelial cells (or better: spindle-shaped
cells with both endothelial and macrophage characteris-
tics), and a large infiltrate of inflammatory cells. Both our
patient samples represent advanced stage nodular KS. At
that stage, inflammatory cells are less prominent. To com-
pare gene expression in KS with gene expression in other
cell types and with other cancers, Pearson correlation co-
efficients were calculated for KS SAGE libraries and pub-
licly available libraries (Table 4). From Table 4 it is
obvious that KS does not highly resemble pure endotheli-
al cells as measured by gene expression profiles (see the
comparison with the two HMVEC libraries, one of which
has been stimulated with VEGF). A better correlation was
observed when KS was compared with a leukocyte library
(CD4) [20], but interestingly the highest correlation coef-
ficient was found when KS was compared to a combined
library of VEGF-stimulated endothelial cells and leuko-
cytes, suggesting that the description of a KS lesion as a
mixture of (aberrant) endothelial cells and an inflamma-
tory infiltrate is reflected in the gene expression profile.
Gene expression in KS does not bear close resemblance to
other types of cancer, as correlation coefficients with sev-
eral cancer types were always low (≤ 0.50, range= 0.21 for
pancreas cancer to 0.50 for prostate cancer). Many fea-
tures of normal skin gene expression are still preserved in
our KS samples (correlation coefficient = 0.66), suggesting
that normal skin can be used as a control material.
Table 1: Primer sequences used for RT-PCR reactions
Gene/fragment size Forward primer 5'-3' Reverse primer 5'-3'
Dual specificity phosphatase: outer set AGT GGG TAC ATC AAG TCC ATC TGA CAC TGG TAT TTT CCA TCA GTG CT
Dual specificity phosphatase: nested set, 239 bp GAA GAG AAA GGA CTC AGT GT AGA TAT ATT TAC AGG ATA GT
Interleukin 1 receptor, type 1: outer set TAA AGT TGT CCT GCT TGA GCT GGA GGC ACG TGA GCC TCT CTT TGC AGT
Interleukin 1 receptor, type 1, nested set, 197 bp AAA TCC AAG ACT ATG AGA CTT AGT GGC TGG TGA CAG T
Tie-1: outer set GAA TGT GCT GGT CGG AGA GAA TGG GGC AGC TTT TCA TAG AGC T
Tie-1: nested set, 131 bp AGA GGA GGT TTA TGT GAA GA ACT ATC TCC CAA AGA AGG ACT
Small inducible cytokine A18: outer set TTC TCT GCC TGC CCA GCA TCA TGA TCA GGC ATT CAG CTT CAG GTC GCT
Small inducible cytokine A18: nested set, 219 bp TGT CCT CGT CTG CAC CAT ATG TAT TTC TGG ACC CAC T
Psoriasin: outer set TGA GCA ACA CTC AAG CTG AGA G TCT CTG GAG GCC CAT TGG T
Psoriasin: nested set, 238 bp TTC ACA AAT ACA CCA GAC GTG AT GGG CGC TGC TCC ATG GCT CTG CT
Sialoadhesin: outer set ATT TAG CAG TAG TTC TAT TGG GCA ACT GAT TAG CAC TTC AGA CGC ACT
Sialoadhesin: nested set, 171 bp CTA GTA GTC AGT TGG GAG T AGC CAG AAC AGC CTT TAC TBMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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Figure 1
Histological staining of AIDS-KS and normal tissues Hematoxylin-eosin staining of normal skin tissue (panel A), and the 
two advanced-stage, nodular AIDS-KS tissues (panels D/G). Endothelial cells were stained with anti-CD31 (Dako) (panel B = 
normal skin, panels E/H = AIDS-KS tissue) and lymphocyte subpopulations were stained with mAbs to CD3 (panel C = normal 
skin, panels F/I = AIDS-KS tissue).BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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Table 2: Frequency distribution of tag counts in the three SAGE libraries
Tag counts KSa KSb NS
≥ 75 55 65 39
25–75 143 151 128
5–24 1317 1146 866
2–4 3518 3444 2908
1 11326 12075 11373
Total tags 45,913 47,316 37,292
Table 3: HHV8 tag counts in the AIDS-KS SAGE libraries For comparison tag numbers for each group were normalized to 50,000.
Tag sequence HHV-8 ID KSa KSb
TCTCCTGTCG ORF59, or Processivity Factor PF8 (DNA replication): secondary 
lytic gene a
80
TTCAAAAACA T0.7 transcript: primary lytic gene a,b 51
TTATACTTTT T1.1 transcript, or NUT-1 /PAN: primary lytic gene a,b 51
TTGGGTCCAC ORF K4.2, or IE-3: secondary lytic gene a 31
CGCGGCGGTG ORF 18: secondary lytic gene a 30
a According to Jenner et al. [31]b Also expressed during latency [31]
Figure 2
Scatterplot analysis of SAGE libraries Scatterplots of KSa versus KSb (A), KSa versus normal skin NS (B) and KSb versus 
NS (C) were generated using the SAS version 6.12 software. The tag frequency for each (per 50,000) is plotted on a logarith-
mic scale for KSa and KSb. The Pearson correlation coefficient of each comparison was calculated.
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Differentially expressed tags between AIDS-KS and normal 
skin
In an effort to identify potential molecular markers for
AIDS-KS we combined the SAGE libraries of the two
AIDS-KS tissues and compared this pooled SAGE library
with a SAGE library generated from pooled samples of
three different normal skin biopsies. Comparison with
normal skin was done essentially to be able to subtract
genes specifically expressed in (normal) epidermis, and of
remnants of normal skin expression in the AIDS-KS biop-
sies. Subtraction should then result in transcripts specific
for AIDS-KS spindle cells and the associated inflammatory
cell population.
Table 5 shows transcripts that were overexpressed in
AIDS-KS compared with normal skin tissue, while Table 6
shows transcripts overexpressed in normal skin compared
with AIDS-KS. Overall, the pattern of expressed genes in
KS shows a reflection of an active process in the skin, in-
cluding transcripts from matrix remodelling genes (matrix
proteases and collagens), angiogenesis-associated genes,
and immune response genes. Among the most abundant
transcripts expressed in AIDS-KS are: collagen type IV α1,
basement membrane collagen, and VE-cadherin, a vascu-
lar endothelial cell marker associated with intercellular
junctions. VE-cadherin expression by KS spindle cells has
been reported before [21]. Collagen type VI α3, a pan
endothelial cell marker associated with angiogenesis [22],
is highly expressed, as is Thy-1, a cell surface antigen, re-
ported to be especially elevated in tumour endothelium
[22]. In Table 7 a comparison of the KS library with (tu-
mour) endothelial markers described by St. Croix et al.
[22] is presented. Many tags expressed by colon (tumour)
endothelium are also present in the KS libraries, albeit
generally at lower tag numbers, suggesting that KS en-
dothelial cells have an expression pattern similar to colon
(tumour) endothelium. The KS libraries were not generat-
ed from purified endothelial tissue, as were the libraries
from St. Croix et al., hence the lower tag numbers. Re-
markable is the complete absence of the endothelial
marker CD146 (Mel-CAM) from the KS libraries. Novel
tumour endothelial markers identified by St. Croix et al.
(TEM1-9) are only partially expressed in KS, and most of
them are thus likely colon specific (Table 7).
Keratins 1, 5, 10 (Table 6), and galectin 7 (52 tags in KS,
63 tags in NS) were expressed in both AIDS-KS and NS li-
braries, both of which contain epidermal tissue. A SAGE
study of isolated human epidermal tissue confirmed that
these three genes are highly expressed in the epidermis
[23]. Keratin 16 was significantly upregulated in the AIDS-
KS lesions, and was absent from normal skin (Table 5).
Keratins 6b, 16 and 17 are in vivo usually seen following
stress and during hyperproliferation. Annexin 1 was iden-
tified as a gene severely downregulated in AIDS-KS (Table
6). The gene product belongs to a family of Ca (2+) de-
pendent phospholipid binding proteins, and has possible
anti-inflammatory activity [24]. Cyclin D1 is also down-
regulated in AIDS-KS, which is suggestive of disturbance
of normal cell cycle control. Downregulation of D-type cy-
clins is often observed in cancer, including those of viral
origin (see ref. [25]). The HHV8-encoded viral cyclin D
gene (v-cyc D) could then act as a substitute for the loss of
cellular cyclin D1, as it is able to interact with a similar,
but not identical set of proteins, resulting in aberrant cell-
cycle progression [26].
Confirmation of SAGE findings
One of our goals was to find transcripts that could be used
as novel prognostic markers for AIDS-KS, preferably meas-
urable in blood. Cells with characteristics of endothelial
macrophages are present in blood and lesions of AIDS-KS
patients [9,10]. We focused on transcripts of adhesion
molecules, secreted proteins or molecules displayed on
the cell surface. Six genes were finally selected based on
upregulated expression in our SAGE libraries: psoriasin,
small inducible cytokine subfamily A member 18, inter-
leukin 1 receptor, dual specificity phosphatase 1, siaload-
hesin and Tie 1 (Table 5). Psoriasin is a S100 calcium-
binding protein, which is chemotactic for CD4+ T lym-
phocytes and neutrophils, and has been implicated in in-
flammatory skin diseases like psoriasis [27]. Cytokine A18
Table 4: Correlation coefficients of KS and public SAGE libraries
SAGE Library 1 SAGE Library 2 Pearson correlation coefficient
KS Duke_HMVEC (acc. GSM706) 0.56
KS Duke_HMVEC + VEGF (acc. GSM707) 0.55
KS CD4 (acc. GSM3245) 0.63
KS (HMVEC/VEGF + CD4) pooled 0.71
KS Fibroblasts, post-crisis (acc. GSM711) 0.54
KS NS (this paper, acc. GSM3242) 0.66
KS Brain (normal), colon cancer, ovary cancer, pancreas cancer, prostate 
cancer, etc.
≤ 0.50BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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Table 5: Tags most significantly overexpressed in KS compared with normal skin. For comparison tag numbers for each group were 
normalized to 50,000
No. Tag ID KS NS
1 GACCGCAGGA Collagen, type IV, α1 (basement membrane collagen)1 1 7 1
2 GTGCGCTGAG MHC, class I C 93 1
3 CGTGGGTGGG Heme oxygenase (decyling) 1 171 5
4 CTCTAAGAAG Complement component 1q subcomponent α peptide 40 1
5 GAGAGTGTCT Tissue inhibitor of metalloproteinase (TIMP) 31 1
6 GCGGTTGTGG Lysosomal-associated multispanning membrane protein 5 28 1
7 CGGGGTGGCC Cartilage oligomeric matrix protein 28 0
8 GCAAGAAAGT Hemoglobin β 24 0
9 ACCGCCGTGG Cytochrome b-245, α polypeptide 22 1
10 CCGGGTGATG ATX1 (antioxidant protein1) 22 1
11 GCTGCGGTCC H2A histone family member 19 1
12 GTGTTAACCA Ribosomal protein L15 19 1
13 ACCATTCTGC Interferon induced transmembrane protein 2 (1-8D) 19 1
14 GGCTCCCACT Heat shock 90 kD protein1, beta 18 0
15 CGGGATTCCT Phospholipid transfer protein 18 1
16 GCTGGTGCCT Thy-1 cell surface antigen 17 1
17 TACAGTATGT Glutamate-ammonia ligase, glutamine synthase 17 1
18 GAGCAGCGCC S100 calcium binding protein A7 (Psoriasin)* 101 8
19 ACTTTAGATG Collagen type VI α33 3 3
20 GTGGCCACGG S100 calcium binding protein A9 (Calgranulin B) 96 8
21 GCCCCTCCGG 16,7 Kd protein (function unknown)1 6 1
22 AGTAGCCGTG No reliable matches 16 1
23 ACAGGGTGAC Endothelial differentiation-related factor 1 15 1
24 TGGAGAAGAG Thioredoxin interacting protein 15 1
25 TGTCATCACA Lysyl oxidase-like 2 (senescence and cell adhesion)1 5 1
26 CTGTTAGTGT Malate dehydrogenase 1, NAD (soluble) 15 1
27 TCACCTTAGG Integral membrane protein 2β 15 0
28 ACAAGTACTG Cadherin 5 type 2, VE-cadherin * (expressed specially in 
endothelial cells)
15 0
29 GATCAATCAG Small inducible cytokine subfamily A member 18* 14 0
30 CAGCTGTCCC Keratin 16 (expressed by hyperproliferative cells) * 12 0
31 GGCTGGTCTG Hypothetical protein MGC4677 28 3
32 ATCTTGTTAC Fibronectin (involved in cell adhesion and migration)1 31
33 GCCGGGTGGG Basigin (Ok blood group) 13 1
34 TCGTAACGAG Hypothetical protein FLJI4987 13 1
35 TGGGTGAGCC Cathepsin B (lysosomal cys protease)7 8 8
36 TGCATCTGGT Heat shock 70 KD protein 5 39 4
37 GTGCTGGACC Proteasome activator subunit 2 13 1
38 GATCAGGCCA Collagen, type III, α1 (blood vessel collagen) 105 11
39 CTGGGTGCCT Immunoglobulin heavy constant gamma 3 (G3 m Marker) 37 4
40 CCAGTGGCCC Ribosomal protein S9 46 5
41 CTAGCCTCAC Actin, gamma 1 25 3
42 CTCATAGCAG Tumor protein, translationally controlled 1 24 3
43 GCGGGGTACC pM5 protein 23 3
44 CTCCCCCAAG Homosapiens SNC73 protein 23 3
45 TCAGACGCAG Prothymosin α 56 6
46 ACCTGTATCC Interferon induced transmembrane protein 3 (1-8U) 90 10
47 ACATAGACCG Serine (or cysteine) proteinase inhibitor clade F, member 1 12 1
48 GCACAACAAG Uncharacterized hypothalamus protein HTMP 12 1
49 TGCTGCCTGT Bone marrow stromal cell antigen 21 22 3
50 CATCACGGAT Interleukin 1 receptor, type 1 * 22 3
51 ATTTAGCAAG Fatty acid binding protein 4, adipocyte * 33 4
52 TCCCCGTACC Lamin A/C 11 1
53 ACAAGGTGCC No reliable matches 11 1
54 CTTGACATAC Dual specificity phosphatase 1* 11 1
55 CCCGGGAGCG PDZ and LIM domain1 (elfin) * 11 1
56 TAGCTGCTGG Splicing factor, arginine/serine-rich 11 * 11 1BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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is a chemokine with a preferential activity for T-lym-
phocytes [28]. The interleukin 1 receptor is involved in
regulation of inflammatory processes, and as such of in-
terest in KS as inflammation is an important aspect of the
disease. Dual specificity phosphatase 1 is a non-receptor
type phosphatase that is highly inducible by oxidative
stress and heat shock in human skin cells [29]. It is
thought to play an important regulatory role in the hu-
man cellular response to environmental stress. Siaload-
hesin, a lectin-like sialic acid-binding receptor, is
expressed on macrophages in a regulated fashion, with
high levels on subsets of macrophages. For example, mac-
rophages present in the perifollicular zones of lymphoid
tissues express sialoadhesin [30] which mediates interac-
tions with lymphocytes [31]. Finally, the Tie receptors are
required for angiogenic remodelling and vessel stabiliza-
tion that occurs subsequent to the initial vasculogenic ac-
tions of VEGFR-1 and VEGFR-2 [32].
To verify the increased expression of these six genes, we
first confirmed tag identity by a method described earlier
[15], using the two original AIDS-KS poly(A) mRNA
isolations. Sequence analysis confirmed that the tag se-
quences indeed belonged to the genes identified by tag
analysis. Then, we used the limited-dilution reverse tran-
scription- (RT-) PCR technique with gene-specific primers
to analyse the expression in five additional AIDS-KS le-
sions and two normal skin biopsies. As shown in figure 3,
the semi-quantitative PCR confirmed the higher expres-
sion levels of five of the six selected genes. However, only
Tie 1 was significantly upregulated in AIDS-KS tumour tis-
sue compared with normal skin (p < 0.05 student t-test).
Sialoadhesin/CD169 mRNA was found to be elevated in
tumour tissue, but the significance of this finding was low
(p > 0.1) due to a substantial standard deviation in the
measurements. However, due to the semi-quantitative
nature of the RT-PCR used it is possible that expression
level differences have been underestimated.
Antibody detection of sialoadhesin/CD169 in tumour tissue
Antibodies to sialoadhesin/CD169 are commercially
available, and were used for histological examination of
AIDS-KS biopsies (Fig. 4). Cells staining positive for anti-
CD169 were identified as tissue macrophages. To confirm
their identity, slides were also stained with anti-CD68 an-
tibodies. CD68 is a transmembrane glycoprotein that is
highly expressed by monocytes and macrophages. Indeed,
in consecutive tissue sections, cells with macrophage-like
morphology stained with the anti-CD169 and with the
anti-CD68 antibodies (Fig. 4).
Discussion
Both AIDS-KS libraries were found to express HHV8 RNA.
The detection of relatively low tag counts for HHV8 spe-
cific ORF's can be explained by only a low percentage of
cells expressing HHV8 RNA. The viral T1.1 and T0.7 tran-
scripts are the predominant viral transcripts found in
AIDS-KS tumours [19] and in primary effusion lympho-
ma (PEL) [33], another disease associated with HHV8. Re-
cently, the global HHV8 genome expression of two PEL
cell lines was studied using viral micro-arrays [34,35]. A
good correlation between the kinetic behaviour of viral
genes in cultured PEL cells and the transcription patterns
observed in AIDS-KS biopsies has been observed [36]. The
pattern of gene expression concurred with the functional
roles of the viral genes. Transcripts corresponding to ORF
K4.2, 18 and 59 were simultaneously expressed in
induced PEL cells and were all classified as secondary lytic
genes. We detected in our SAGE libraries only tags belong-
ing to the five HHV8 ORF's mentioned before, suggesting
that these genes are expressed at significantly higher levels
than the other HHV8 genes. HHV8 contains many poly-
cistronic mRNAs, where expression of the 5' ORF cannot
be detected using SAGE. However, as transcription of both
ORF's is coupled, we do not think that this problem inter-
feres with our SAGE analysis, as detecting tags for a
downstream ORF should indicate that the upstream ORF
is also expressed.
57 GTGCTGGTGC Potassium channel subfamily K, member 6 / angiopoietin 
like 4
11 0
58 GTTAACGTCC Ribosomal protein L44 21 3
59 CCAGGGGAGA Interferon, alpha-inducible protein 27 31 4
60 TGGCCCCACC Pyruvate kinase, muscle 10 1
61 GGAAGCTAAG Osteoblast specific factor 2 (fascilin I-like) * 10 1
62 TAGTTGATGG Galectin 1 * 10 1
63 CTCCATTGCC Sialoadhesin /CD169* 7 0
64 CCCTGTTCAG Tie 1* 13 2
* Low frequency of appearance in public SAGE libraries
Table 5: Tags most significantly overexpressed in KS compared with normal skin. For comparison tag numbers for each group were 
normalized to 50,000 (Continued)BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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In an earlier study, Poole et al. [37] presented changes in
gene expression of cultured dermal microvascular en-
dothelial cells after HHV8 infection as measured by mi-
cro-array screening. A total of 14 genes were subsequently
confirmed by real-time PCR to be upregulated. Six of
these, calgranulin B, CD14, RDC1, TGF-β3, TIMP1 and
von Willebrand factor, also showed increased tag num-
bers in our in vivo analysis of AIDS-KS. However, cell lines
have in general proven to be quite different from primary
cells in their gene expression profile [38]. Earlier, immu-
nohistochemistry showed that KS spindle cells in tissue
stain positive for CD14 and von Willebrand factor [5].
Vascular endothelial growth factor (VEGF) is one of the
most important agonists of angiogenesis. It is a secreted
protein that induces vascular permeability and endotheli-
al cell proliferation. The spindle cells of primary AIDS-KS
lesions express and secrete VEGF [39]. The most abundant
differentially expressed tag in AIDS-KS represents collagen
type IV α1, a gene induced by VEGF, emphasizing the im-
portance of VEGF in AIDS-KS development. However, tags
for VEGF, VEGF-B, VEGF-C, and VEGF-D were absent or
nearly absent from libraries KSa and KSb, as were tags for
platelet-derived growth factors (PDGFα/β and PDGF-C),
and fibroblast growth factor 4, sometimes referred to as
the KS oncogene [40]. Tags representing endothelial VEGF
receptors, namely VEGFR-1, VEGFR-2 and VEGFR-3, were
not found amongst the most abundant differentially ex-
pressed genes (Table 5), confirming an earlier in vitro
study [37]. However, Tie-1 receptor mRNA, belonging to
another subfamily of VEGFR receptors, was increased in
AIDS-KS. The ligand for Tie1 remains as yet to be identi-
Table 6: Tags overexpressed in normal skin compared with KS. For comparison tag numbers for each group were normalized to 50,000 
transcripts
No. Tag ID KS NS
1 AGAAAGATGT Annexin A1 2 18
2 AAGGCAATTT Vascular Rab-GAP/TBC-containing/Homo sapiens cDNA FLJ11739 fis, clone 
HEMBA1005497
21 4
3 GCTGCCCTGG Centaurin, gamma 3/CDP-diacylglycerol – inositol 3-phosphatidyltransferase 
(phosphatidylinositol synthase)
21 4
4 TGCGCCTTTA No reliable matches 2 13
5 ACATTTCAAA Keratin 1 11 77
6 GCCCCTGCTG Keratin 5 82 219
7 GAAAACAAAG Keratin 10 14 122
8 GCAAAACTCC Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glyco-
protein)/ Homo sapiens cDNA FLJ13686 fis, clone PLACE2000047
21 6
9 AATAAATTCC Neuroblastoma, suppression of tumorigenicity 1 3 25
10 GGGAAACCCC Dipeptidylpeptidase 9/ Homo sapiens cDNA: FLJ21289 fis, clone COL01938 4 33
11 AGATGAGATG Core promoter element binding protein 3 24
12 CCTCTGCACT DnaJ protein SB73/ ESTs, Weakly similar to A46010 X-linked retinopathy 
protein (C-terminal, clone XEH.8c)
32 4
13 AAAGTCTAGA Cyclin D1 2 15
14 CAAAAAAAAA Multiple (n = 26) 2 15
15 TCACCCAGGG No reliable matches 2 14
16 GGCCCCTCAC Insulin-like growth factor binding protein 6/ zinc finger protein 262 4 25
17 AGAATCGCTT Coatomer protein complex, subunit alpha/ expressed in activated T/LAK 
lymphocytes
74 9
18 ATTTGAGAAG RAD23 homolog B (S. cerevisiae) 7 49
19 TCTAACAACG No reliable matches* 0 94
20 AATTTGCAAA Homo sapiens cDNA FLJ13582 fis, clone PLACE1009048 0 44
21 TCTCCATACC No reliable matches 0 42
22 CCCATCGCCT No reliable matches 0 33
23 CCCATCGGCC No reliable matches* 0 18
24 CCACGGGATT Collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal 
dominant)
01 5
25 GCTTTCTCAC No reliable matches 0 14
26 TCACCGGCAG Tag not found in any mRNA sequence, tag not seen in any public SAGE 
library*
01 4
27 ACCCCGGGAG No reliable matches* 0 11
28 TTAAAAAAAA Hypothetical protein PRO2521/ matrin 3 0 10
* Low frequency of appearance in public SAGE librariesBMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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Table 7: Endothelial markers expressed in normal and tumour endothelial cells (ECs) and in KS. For comparison tag numbers for each 
group were normalized to 100,000 transcripts. Endothelial markers were derived from [22]. Tumour endothelial markers derived from 
colon cancer endothelium are shown in bold.
Tag ID Normal ECs Tumour ECs KS
CATATCATTAA Angiomodulin 247 501 120
TGCACTTCAAG Hevin 328 141 90
TTTGCACCTTT Connective tissue growth factor 165 84 41
TTGCTGACTTT Collagen, type VI α1 73 131 101
ACCATTGGATT Interferon induced transmembrane protein 102 67 19
ACACTTCTTTC Guanine nucleotide binding protein 11 104 44 35
TTCTGCTCTTG Von Willebrand factor 71 67 49
TCCCTGGCAGA Cysteine-rich protein 2 (CRP-2, ESP-1) 66 68 8
TAATCCTCAAG Collagen, type XVIII α 26 106 26
ATGTCTTTTCT Insulin-like growth factor-binding protein 4 58 65 19
GGGATTAAAGC CD146 endothelial marker 40 67 0
TTAGTGTCGTA SPARC (osteonectin, BM-40 38 69 22
TTCTCCCAAAT Collagen, type IV α22 0 8 6 9
GTGCTAAGCGG Collagen, type VI α22 4 7 4 9
GTTTATGGATA Matrix Gla protein (MGP) 35 56 22
CCCTGTTCAGC TIE-1 14 15 13
CCCTTGTCCGA PEM1 EST 131 104 11
CCCTTTCACAC PEM2 EST 52 33 3
CAACAATAATA PEM3 EST 42 25 4
GGCCCTACAGT PEM4 EST 26 13 5
GCTAACCCCTG PEM5 EST 7 31 9
GGCACTCCTGT PEM6 EST 22 13 4
TCACAGCCCCC PEM7 EST 20 15 8
TTTCATCCACT PEM8 EST 20 13 3
ATACTATAATT PEM9 EST 25 6 0
AATAGGGGAAA PEM10 EST 13 19 3
GGAAATGTCAA MMP-2 (gelatinase A, 72-kD type IV 
collagenase)
13 1 5 2
TTTGGTTTTCC Collagen, type I α2, transcript A 5 139 110
ATTTTGTATGA Nidogen (entactin) 0 13 6
ACTTTAGATGG Collagen, type VI α3 1 23 66
GAGTGAGACCC Thy-1 cell surface antigen 3 63 33
TTAAATAGCAC Collagen, type I α12 3 3 2
GTTCCACAGAA Collagen, type I α2, transcript B 0 9 19
TCCCCCAGGAG Bone morphogenetic protein 1 
(metalloprotease)
11 6 4 0
CTTTCTTTGAG Regulated in glioma-like 7–1 0 22 1
CAGGAGACCCC MMP-11 (stromelysin 3) 0 16 1
GTACACACACC Cystatin S 01 0 0
CCACAGGGGAT Collagen, type III α1 2 38 182
GGGGCTGCCCA TEM1, similarity to thrombomodulin 0 28 26
GATCTCCGTGT TEM2, similarity to rat Rhes ras-related protein 0 25 0
CATTTTTATCT TEM3, ESTs 0 23 1
TATTAACTCTC TEM4, similarity to JNK interacting protein-3a 0 21 2
TTTTTAAGAAC TEM5, ESTs 0 14 0
TTAAAAGTCAC TEM6, ESTs 1 19 1
ACAGACTGTTA TEM7, similarity with sea squirt nidogen 4 74 2
CTATAGGAGAC TEM8, similarity with homeobox protein DLX-3 1 18 8
GCCCTTTCTCT TEM9, Endo 180 lectin (macrophage mannose 
receptor family)
11 7 1 3BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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fied. Interestingly, the activating ligand for Tie-2, angiopo-
etin-4, was detected in both AIDS-KS libraries. These
results partly confirm the in situ hybridisation work of
Brown et al [41] that showed expression of angiopoietin-
2, Tie-1 and Tie-2 in the spindle cells of AIDS-KS.
Among the most abundantly expressed tags in AIDS-KS
are the S100 calcium-binding proteins, S100A7/psoriasin,
and S100A9/calgranulin B. S100 proteins have been
implicated in diverse cellular processes including cell pro-
liferation, apoptosis, differentiation, invasion and metas-
tasis [42]. Psoriasin was originally identified as a protein
whose levels are increased in psoriatic keratinocytes [27].
Subsequently, psoriasin was also found to be upregulated
in abnormally differentiating primary keratinocytes, in sq-
uamous carcinomas [43] and in a subset of oestrogen-re-
ceptor negative tumours [44]. Our KS tissues exhibit
several similarities with psoriatic skin, probably reflecting
a common hyperproliferative or inflammatory process.
Firstly, we observed an altered terminal differentiation of
keratinocytes as indicated by the aberrant expression of
keratins. Secondly, in AIDS-KS the capillary loops extend
into the dermal papillae, and are in close proximity with
the epidermis, a characteristic also observed in psoriasis.
Thirdly, there is high expression of psoriasin in our SAGE
AIDS-KS libraries. Calgranulin B is expressed by macro-
phages in acutely inflamed tissues and in chronic inflam-
mation [45], and is also induced in epithelial cells during
dermatoses.
An upregulation of keratin 16 in AIDS-KS was observed. A
strong induction of keratin 16 occurs after physical injury
to the human epidermis and is an active part of the epider-
mal response to wound healing. Keratin 16 is also abun-
dant in many hyperproliferative disorders, including
psoriasis, lamellar ichthyosis and chronic irritant dermati-
tis [46–48]. Expression of epidermal keratins 1, 5, and 10
was lower in KS than in normal skin (Table 6), suggesting
that epidermal gene expression is also affected.
Sialoadhesin/CD169 is a 1709aa macrophage-restricted
membrane glycoprotein, a prototypical member of the Si-
glec family of sialic acid binding immunoglobulin (Ig)-
like lectins, which are involved in cellular interactions
Figure 3
Semi-quantitative RT-PCR analysis of differentially expressed genes PCR-analysis was performed for six genes on 
cDNA generated from normal skin tissues or different AIDS-KS tissues. Expression level indicated the 10-fold dilution step 
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[32]. Macrophages express multiple receptors found also
on other leukocytes. Only a restricted few are exclusively
assigned to macrophages and are hence implicated in spe-
cific macrophage functions. Sialoadhesin/CD169, or si-
glec-1, is one such receptor, which is particularly found on
activated macrophages in chronic inflammation and
tumours. Recently, it has been suggested that sialoadhesin
contributes to cell-cell and cell-matrix interactions of mac-
rophages during inflammatory reactions [31]. Antibodies
to sialoadhesin specifically stained tumour macrophages
in different AIDS-KS biopsies. Cells that stained positive
for CD169 were morphologically identical to cells that
stained with anti-CD68 antibodies in consecutive tissue
sections, confirming their identity as macrophages. HHV8
is known to replicate in monocytes/macrophages found
in KS lesions [5,49], so these types of cells may contribute
significantly to the transmission of the virus and to the in-
crease of the HHV8 load generally observed in late stages
of the disease [50,51]. The finding of an increased expres-
sion of sialoadhesin in PBMC of AIDS-KS patients (un-
published observation) suggests that the stained
macrophages in KS lesions are recruited from the circula-
tion rather than produced locally. This hypothesis is
strengthened by the fact that peripheral blood cells of KS
patients contain macrophage-related cells that can differ-
entiate in culture into adherent spindle cells [21,52].
This manuscript describes the SAGE analysis of normal
skin versus AIDS-KS skin tissue and revealed that several
genes are aberrantly expressed in AIDS-KS. Focusing on
transcripts overexpressed in AIDS-KS, we showed that
Tie1 is elevated in AIDS-KS tissue. Besides, we identified a
new marker of AIDS-KS, sialoadhesin. Sialoadhesin/
CD169 is highly expressed by subsets of macrophages,
namely those present in the perifollicular zones of lymph
nodes and spleen, in macrophages of the liver (including
Kuppfer cells), lamina propia macrophages of the colon,
perivascular macrophages of the brain, and alveolar and
interstitial macrophages of the lung. CD169 expression is
also found on activated macrophages in chronic inflam-
mation and tumours. Kaposi's sarcoma is characterized by
the simultaneous emergence of multiple lesions. Our
findings suggest that activated sialoadhesin-expressing
macrophages may play a role in this process, as hypothe-
sized earlier by Ensoli et al. [53]. The clinical value of
sialoadhesin expression is currently being evaluated in
our cohort of HIV infected patients.
Conclusions
The expression profile of AIDS-KS showed 64 genes to be
significantly upregulated, and 28 genes downregulated,
compared with normal skin. One of the genes with in-
creased expression was sialoadhesin (CD169). Antibodies
Figure 4
Photomicrographs of anti-CD68 and anti-CD169 stained sections of selected tissues The two frozen skin biopsies 
show a similar histopathological picture of nodular stage Kaposi's sarcoma. Left panels (A/D): HE staining; middle panels (B/E): 
αCD68 staining; Right panels (C/F): αCD169 staining. Throughout the dermis, vascular proliferations are found surrounded by 
irregular, rather dense areas of atypical spindle cell proliferations. Both lesions contain sparse inflammatory cell infiltrates, 
mainly consisting of CD68+ macrophages.BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/7
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to sialoadhesin/CD169 specifically labelled tumour-asso-
ciated macrophages, suggesting that macrophages present
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